|
2026 Conference Publication International Mapping of Access to Genetic Testing for Interstitial Lung Disease (ILD)Stanel, S., Lough, G., Emery, H., Adegunsoye, A. O., Aguiar, F. M., Bonella, F., Borie, R., Buendia-Roldan, , Chambers, D., Duckworth, A., Froidure, A., Hunninghake, G. M., Hurley, K. J., Johannson, K. A., Kam, M. L., Kulkarni, T., Mackintosh, J., Molina-Molina, M., Newton, C., Renzoni, E., Wolters, P., Zhang, D., Corte, T. J. and Rivera Ortega, P. (2026). International Mapping of Access to Genetic Testing for Interstitial Lung Disease (ILD). OXFORD: OXFORD UNIV PRESS. doi: 10.1093/ajrccm/aamag162.2493 |
|
2026 Conference Publication Palivizumab in donor derived RSV infection in an adult bilateral lung transplant recipientMeharry, R.S., Vale, C., Winks, L., Vemuri, K., Tse, T., Carew, A., Chambers, D., Trotter, M., Fiene, A., Divithotawela, C., Bell, P., Zhang, L., Hopkins, P. and Mackintosh, J. (2026). Palivizumab in donor derived RSV infection in an adult bilateral lung transplant recipient. 46th Annual Meeting & Scientific Sessions of the International Society for Heart and Lung Transplantation (ISHLT) (ISHLT2026), Totonto, ON Canada, 22-26 April 2026. Philadelphia, PA United States: Elsevier. doi: 10.1016/j.healun.2026.02.782 |
|
2026 Conference Publication The relationship between anti-ro antibodies, phenotype and outcomes in the Australasian Interstitial Lung Disease RegistryWatson, Stella, Hansen, Dylan, Glaspole, Ian, Glenn, Laura, Goh, Nicole, Mackintosh, John, Symons, Karen, Wilsher, Margaret, Wrobel, Jeremy, Chambers, Daniel, D'costa, Jason, De Boer, Sally, Edwards, Adrienne, Gabbay, Eli, Gallagher, Henry, Grainge, Christopher, Keir, Gregory, Kwan, Ben, Lim, K. P., Moodley, Yuben, Moore, Irene, Navaratnam, Vidya, Ong, Chong, Polasek, Jonathon, Reynolds, Paul, Teoh, Alan, Thien, Frank, Troy, Lauren, Veitch, Elizabeth ... Parker, Matthew J. S. (2026). THE RELATIONSHIP BETWEEN ANTI-RO ANTIBODIES, PHENOTYPE AND OUTCOMES IN THE AUSTRALASIAN INTERSTITIAL LUNG DISEASE REGISTRY. HOBOKEN: WILEY. |
|
2026 Conference Publication Impact of the size of FVC decline on lung transplant-free survival among the Australasian Interstitial Lung Disease Registry (AILDR) patientsLi, Andrew, Stewart, Iain, Higginson, Emily, Buck, Evan, Teoh, Alan, Glenn, Laura, Troy, Lauren, Glaspole, Ian, Symons, Karen, Wilsher, Margaret, De Boer, Sally, Wrobel, Jeremy, Moodley, Yuben, Thien, Francis, Gallagher, Henry, Chambers, Daniel, Mackintosh, John, Goh, Nicole, Khor, Yet, Edwards, Adrienne, Grainge, Christopher, Kwan, Benjamin, Keir, Gregory, Ong, Chong, Reynolds, Paul, Veitch, Elizabeth, Gabbay, Eli, Pin, Lim Kuan, Polasek, Jonathon ... Corte, Tamera (2026). IMPACT OF THE SIZE OF FVC DECLINE ON LUNG TRANSPLANT-FREE SURVIVAL AMONG THE AUSTRALASIAN INTERSTITIAL LUNG DISEASE REGISTRY (AILDR) PATIENTS. HOBOKEN: WILEY. |
|
2026 Conference Publication The Australasian Interstitial Lung Disease Registry (AILDR): demographics, disease characteristics, and transplant-free survival insights from a bi-national cohortFraser, A., Zhao, C., Glaspole, , Glenn, L., Goh, N., Mackintosh, J., Symons, K., Wilsher, M., Chambers, D., D'Costa, J., de Boer, S., Edwards, A., Gabbay, E., Gallagher, H., Grainge, C., Keir, G., Khor, Y., Kwan, B., Lim, K. P., Moodley, Y., Moore, , Navaratnam, , Ong, C., Polasek, J., Reynolds, P., Teoh, A., Thien, F., Troy, L., Veitch, E. ... Corte, T. (2026). THE AUSTRALASIAN INTERSTITIAL LUNG DISEASE REGISTRY (AILDR): DEMOGRAPHICS, DISEASE CHARACTERISTICS, AND TRANSPLANT-FREE SURVIVAL INSIGHTS FROM A BI-NATIONAL COHORT. HOBOKEN: WILEY. |
|
2026 Conference Publication Immunohistochemical expression within lung disease including carcinoma, with reference to cell lineage, the tumour microenvironment and elastin related proteinsDuhig, Edwina, van Zwieten, Anthony, Broomfield, Amy, Walsh, Michael, Lal, Sameeta, Godbolt, David, Davidson, Morgan, Mackintosh, John, Hopkins, Peter, Chambers, Daniel, Bowman, Rayleen, Fong, Kwun and Yang, Ian (2026). Immunohistochemical expression within lung disease including carcinoma, with reference to cell lineage, the tumour microenvironment and elastin related proteins. Pathology Update 2026, Sydney, NSW Australia, 6-8 March. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.pathol.2026.01.049 |
|
2025 Conference Publication Efficacy and Safety of Danazol in Pulmonary Fibrosis Associated With Short Telomeres: A Phase 2 Randomized Clinical TrialMackintosh, J., Wells, J., Lutzky, V., Yerkovich, S.T., Yeh, R., Hsu, A., Pickett, H., Pietsch, M., Cooper, B., Enever, D., Bancroft, S., Apte, S., Tan, M., Dickinson, J., Lucas, S., Selvadurai, H., Grainge, C., Hopkins, P., Glaspole, I., Reynolds, P.N., Wrobel, J.P., Goh, N., Corte, T.J. and Chambers, D. (2025). Efficacy and Safety of Danazol in Pulmonary Fibrosis Associated With Short Telomeres: A Phase 2 Randomized Clinical Trial. ATS International Conference, San Francisco, CA United States, 16-21 May 2025. New York, NY United States: American Thoracic Society. doi: 10.1164/ajrccm.2025.211.abstracts.a1010 |
|
2025 Conference Publication Deep learning quantitative computed tomography analysis in the Australian idiopathic pulmonary fibrosis registryMackintosh, J., Fermoyle, C., Bussell, E., Thillai, M., Jo, H., Glaspole, , Grainge, C., Goh, N., Hopkins, P., Moodley, Y., Reynolds, P., Zappala, C., Keir, G., Cooper, W., Mahar, A., Ellis, S., Wells, A., Walsh, S. and Corte, T. (2025). DEEP LEARNING QUANTITATIVE COMPUTED TOMOGRAPHY ANALYSIS IN THE AUSTRALIAN IDIOPATHIC PULMONARY FIBROSIS REGISTRY. HOBOKEN: WILEY. |
|
2025 Conference Publication A digital self-management package for people with interstitial lung disease: the REBUILD-SM clinical trial - an updateBarton, C., Glenn, L., Lee, J., Cox, N., Hoffman, M., Cox, , Palmer, A., Keech, A., Laranjo, L., Goh, N., Chambers, D., Mackintosh, J., Glaspole, , Troy, L., Knibbs, L., Moodley, Y., Brooke, M., Holland, A. and Corte, T. (2025). A DIGITAL SELF-MANAGEMENT PACKAGE FOR PEOPLE WITH INTERSTITIAL LUNG DISEASE: THE REBUILD-SM CLINICAL TRIAL-AN UPDATE. HOBOKEN: WILEY. |
|
2025 Conference Publication Combined deep learning algorithms demonstrate that both computed tomography phenotype and anatomical biomarkers are predictive of prognosis and progression in idiopathic pulmonary fibrosisMackintosh, J., Fermoyle, C., Bussell, E., Thillai, M., Jo, H., Glaspole, , Grainge, C., Goh, N., Hopkins, P., Moodley, Y., Reynolds, P., Zappala, C., Keir, G., Cooper, W., Mahar, A., Ellis, S., Wells, A., Walsh, S. and Corte, T. (2025). COMBINED DEEP LEARNING ALGORITHMS DEMONSTRATE THAT BOTH COMPUTED TOMOGRAPHY PHENOTYPE AND ANATOMICAL BIOMARKERS ARE PREDICTIVE OF PROGNOSIS AND PROGRESSION IN IDIOPATHIC PULMONARY FIBROSIS. HOBOKEN: WILEY. |
|
2024 Conference Publication Multi-centre experience of elexacaftor-tezacaftor-ivacaftor use in adult cystic fibrosis transplant recipients in QueenslandWood, Michelle, Smith, Iain, Hiscock, Keirran, Smith, Daniel, Keating, Rebecca, Burr, Lucy, Tay, George, Zimmerman, Maureen, Feather, Iain, Cobb, Robyn, Moore, Vanessa, Evans, Ieuan, Reid, David, Masel, Philip, Mackintosh, John and Henderson, Daniel (2024). Multi-centre experience of elexacaftor-tezacaftor-ivacaftor use in adult cystic fibrosis transplant recipients in Queensland. 15th Australasian Cystic Fibrosis Conference, Brisbane, QLD Australia, 2-4 August 2024. Richmond, VIC Australia: John Wiley & Sons. |
|
2024 Conference Publication Artificial intelligence- based decision support for HRCT stratification in fibrotic lung disease: an international study of 195 observers from 43 countriesWalsh, S. L., Wells, A. U., Calandriello, L., Felder, F., Mackintosh, J., Glaspole, I., Goh, N., Grainge, C., Hopkins, P., Moodley, Y. P., Vidya, N., Reynolds, P. N. and Corte, T. J. (2024). Artificial Intelligence- based Decision Support for HRCT Stratification in Fibrotic Lung Disease: An International Study of 195 Observers From 43 Countries. NEW YORK: AMER THORACIC SOC. |
|
2024 Conference Publication The Assist CLAD Study - Mesenchymal Stromal Cell Therapy in Chronic Lung Allograft DysfunctionChambers, D.C., Westall, G., Darley, D., Glanville, A., Malouf, M., Musk, M., Sturm, M., Holmes-Liew, C., Lawrence, S., Bushell, D., Holsworth, L., Lawson, N., Singleton, L., Timmins, S., Enever, D., Wildermuth, H., Daka, O., Cooper, B., Apte, S.H., Pham, A., Haines, S., Zhang, L., Tan, M., Groves, P., Lutzky, V.P., Levvey, B., Cristiano, Y., Yaw, M., Winks, L. ... Hopkins, P. (2024). The Assist CLAD Study - Mesenchymal Stromal Cell Therapy in Chronic Lung Allograft Dysfunction. ISHLT 44th Annual Meeting and Scientific Sessions, Prague, Czech Republic, 10-13 April 2024. Philadelphia, PA United States: Elsevier. doi: 10.1016/j.healun.2024.02.016 |
|
2024 Conference Publication Longitudinal Increases in Bronchoalveolar Lavage Interleukin-6, Interleukin-8, Macrophage Inflammatory Protein-1a, and Transforming Growth Factor ß Predict Progressive Chronic Lung Allograft DysfunctionO'Sullivan, B., Tan, M., Apte, S.H., de Silva, T., Groves, P., Lutzky, V.P., Westall, G., Darley, D., Musk, M., Glanville, A., Malouf, M., Holmes-Liew, C., Sturm, M., Lawrence, S., Bushell, D., Holsworth, L., Lawson, N., Singleton, L., Timmins, S., Enever, D., Wildermuth, H., Daka, O., Cooper, B., Pham, A., Winks, L., Haines, S., Zhang, L., Levvey, B., Cristiano, Y. ... Chambers, D.C. (2024). Longitudinal Increases in Bronchoalveolar Lavage Interleukin-6, Interleukin-8, Macrophage Inflammatory Protein-1a, and Transforming Growth Factor ß Predict Progressive Chronic Lung Allograft Dysfunction. ISHLT 44th Annual Meeting and Scientific Sessions, Prague, Czech Republic, 10-13 April 2024. Philadelphia, PA United States: Elsevier. doi: 10.1016/j.healun.2024.02.425 |
|
2024 Conference Publication Idiopathic pulmonary fibrosis update: AILDR in comparison with AIPFRChee, M., Khor, Y., Jackson, D., Chambers, D., de Boer, S., D'Costa, J., Edwards, A., Gabbay, E., Galbraith, M., Gallagher, H., Glaspole, , Goh, N., Grainge, C., Keir, G., Kwan, B., Lake, F., Mackintosh, J., Moodley, Y., Moore, , Ong, C., Reynolds, P., Royals, K., Teoh, A., Troy, L., Veitch, E., Wilsher, M., Wrobel, J., Corte, T. and Thien, F. (2024). Idiopathic pulmonary fibrosis update: AILDR in comparison with AIPFR. HOBOKEN: WILEY. |
|
2024 Conference Publication The utility of genetic testing in adults with pulmonary fibrosis: a retrospective cohort studyDixon, O., Lutzky, , Zhang, L., Watson, S., Rodgers, D., Chambers, D. and Mackintosh, J. (2024). The utility of genetic testing in adults with pulmonary fibrosis: A retrospective cohort study. HOBOKEN: WILEY. |
|
2024 Conference Publication Telomere length in Australian adults with pulmonary fibrosisMackintosh, J., Zhang, L., Lutzky, , Tan, M., Apte, S., Groves, P., O'Sullivan, B., Watson, S., Dixon, O., Hopkins, P., Corte, T. and Chambers, D. (2024). Telomere length in Australian adults with pulmonary fibrosis. HOBOKEN: WILEY. |
|
2024 Conference Publication The genetic landscape of familial interstitial lung disease (ILD) is similar to sporadic idiopathic pulmonary fibrosis (IPF)Lucas, S., Raspin, K., Mackintosh, J., Glaspole, , Reynolds, P., Troy, L., Schwartz, D., Richard, Wood-Baker R., Walsh, S., Moodley, Y., Walters, E., Chambers, D., Corte, T. and Dickinson, J. (2024). The genetic landscape of familial interstitial lung disease (ILD) is similar to sporadic idiopathic pulmonary fibrosis (IPF). HOBOKEN: WILEY. |
|
2023 Conference Publication Deep learning-based quantification of traction bronchiectasis severity for predicting outcome in idiopathic pulmonary fibrosisFelder, Federico, Nan, Yang, Yang, Guang, Mackintosh, John, Calandriello, Lucio, Silva, Mario, Glaspole, Ian, Goh, Nicole, Cooper, Wendy, Grainge, Christopher, Hopkins, Peter, Moodley, Yuben, Vidya, Navaratnam, Reynolds, Paul, Wells, Athol, Corte, Tamera and Walsh, Simon (2023). Deep learning-based quantification of traction bronchiectasis severity for predicting outcome in idiopathic pulmonary fibrosis. Annual congress of the European-Respiratory-Society (ERS), Milan Ia, Sep 09-13, 2023. SHEFFIELD: EUROPEAN RESPIRATORY SOC JOURNALS LTD. doi: 10.1183/13993003.congress-2023.OA4853 |
|
2023 Conference Publication A deep learning algorithm for predicting disease progression in idiopathic pulmonary fibrosisFang, Yingying, Felder, Federico, Yang, Guang, Mackintosh, John, Calandriello, Lucio, Silva, Mario, Cooper, Wendy, Glaspole, Ian, Goh, Nicole, Grainge, Christopher, Hopkins, Peter, Moodley, Yuben, Vidya, Navaratnam, Reynolds, Paul, Wells, Athol, Corte, Tamera and Walsh, Simon (2023). A deep learning algorithm for predicting disease progression in idiopathic pulmonary fibrosis. Annual congress of the European-Respiratory-Society (ERS), Milan Ia, Sep 09-13, 2023. SHEFFIELD: EUROPEAN RESPIRATORY SOC JOURNALS LTD. doi: 10.1183/13993003.congress-2023.OA4852 |
